Dextromethorphan, chlorphenamine and serotonin toxicity: Case report and systematic literature review

British Journal of Clinical Pharmacology

Volumn 70, Issue 6, 2010, Pages 794-798

  Monte, Andrew A ^a,b   Chuang, Ryan ^a,b   Bodmer, Michael ^a,c  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

5 HT; Chlorphenamine; Dextromethorphan; Poisoning; Serotonin toxicity

Indexed keywords

CHLORPHENIRAMINE; CORICIDIN; DEXTROMETHORPHAN; INFUSION FLUID; LORAZEPAM; PAROXETINE; SEROTONIN AGONIST; ZIMELDINE;

ADULT; BORDERLINE STATE; CASE REPORT; CLINICAL EVALUATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INTOXICATION; DRUG OVERDOSE; DRUG POTENCY; DRUG STRUCTURE; ELECTROCARDIOGRAM; HUMAN; INGESTION; MALE; MEDICAL LITERATURE; MEDLINE; MYDRIASIS; PANIC; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROTONIN TOXICITY; SINUS TACHYCARDIA; SUICIDE ATTEMPT; TABLET; TOXICITY;

ANTITUSSIVE AGENTS; CHLORPHENIRAMINE; DEXTROMETHORPHAN; HUMANS; MALE; OVERDOSE; SEROTONIN AGENTS; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 78349258991     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03747.x     Document Type: Review

References (24)

1. Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care 2007; 23: 829-31.
2. Navarro A, Perry C, Bobo WV. A case of serotonin syndrome precipitated by abuse of the anticough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium. Gen Hosp Psychiatry 2006; 28: 78-80.
3. Schwartz AR, Pizon AF, Brooks DE. Dextromethorphan-induced serotonin syndrome. Clin Toxicol (Phila) 2008; 46: 771-3.
4. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352: 1112-20.
5. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96: 635-42.
6. Alisky JM. Can chlorpheniramine cause serotonin syndrome? Singapore Med J 2006; 47: 1014.
7. Karamanakos PN. Can chlorpheniramine cause serotonin syndrome? Singapore Med J 2007; 48: 482. author reply 483.
8. Skop BP, Finkelstein JA, Mareth TR, Magoon MR, Brown TM. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1994; 12: 642-4.
9. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth 2005; 95: 434-41.
10. Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care 2004; 20: 858-63.
11. Kim HS, Park IS, Lim HK, Choi HS. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice. Arch Pharm Res 1999; 22: 113-8.
12. Carlsson A, Lindqvist M. Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J Pharm Pharmacol 1969; 21: 460-4.
13. Carlsson A, Wong DT. Correction: a note on the discovery of selective serotonin reuptake inhibitors. Life Sci 1997; 61: 1203.
14. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997; 340: 249-58.
15. Yeh S, Dersch C, Rothman R, Cadet J. Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats. Synapse 1999; 33: 207-17.
16. Codd EE, Shank RP, Schupsky JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther 1995; 274: 1263-70.
17. Lidbrink P, Jonsson G, Fuxe K. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology 1971; 10: 521-36.
18. Shishido S, Oishi R, Saeki K. In vivo effects of some histamine H1-receptor antagonists on monoamine metabolism in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 1991; 343: 185-9.
19. Young CS, Mason R, Hill SJ. Inhibition by H1-antihistamines of the uptake of noradrenaline and 5-HT into rat brain synaptosomes. Biochem Pharmacol 1988; 37: 976-8.
20. Miyata S, Hirano S, Ohsawa M, Kamei J. Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice. Psychopharmacology (Berl) 2009 [Epub ahead of print].
21. Karamanakos PN, Pappas P, Marselos M. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors. Behav Brain Res 2004; 148: 199-208.
22. Oates JA, Sjoerdsma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 1960; 10: 1076-8.
23. Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999; 49: 871-4.
24. Smith SM, Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2008; CD001831.